Clinical Trials Browser

Interventional × Polycythemia Vera × pomalidomide × Clear all

NCT00669578 2019-12-30

CC-4047 in Treating Patients With Myelofibrosis

Phase 1/2 Completed

77 enrolled 9 charts

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT01243944 2019-03-06

Study of Efficacy and Safety in Polycythemia Vera Subjects Who Are Resistant to or Intolerant of Hydroxyurea: JAK Inhibitor INC424 (INCB018424) Tablets Versus Best Available Care: (The RESPONSE Trial)

Phase 3 Completed

222 enrolled 21 charts

Polycythemia Vera